Vincerx Pharma, Inc. (VINC): Price and Financial Metrics
VINC Price/Volume Stats
| Current price | $0.21 | 52-week high | $9.37 |
| Prev. close | $0.21 | 52-week low | $0.18 |
| Day low | $0.18 | Volume | 685,100 |
| Day high | $0.22 | Avg. volume | 673,833 |
| 50-day MA | $0.30 | Dividend yield | N/A |
| 200-day MA | $1.16 | Market Cap | 6.97M |
VINC Stock Price Chart Interactive Chart >
Vincerx Pharma, Inc. (VINC) Company Bio
Vincerx Pharma, Inc. operates as a clinical-stage life sciences company. The Company focuses on developing VIP152 inhibits PTEFb phosphorylation of RNA polymerase II (RNAPII), thereby preventing transcription elongation and blocking expression of genes that drive cancer. Vincerx Pharma serves customers worldwide.
VINC Price Returns
| 1-mo | -17.97% |
| 3-mo | -71.25% |
| 6-mo | -64.51% |
| 1-year | -75.64% |
| 3-year | -97.96% |
| 5-year | N/A |
| YTD | -82.20% |
| 2023 | 15.69% |
| 2022 | -89.99% |
| 2021 | -51.27% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...